The Use of Bifunctional NOP/Mu and NOP Receptor Selective Compounds for the Treatment of Pain, Drug Abuse, and Psychiatric Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|42|7451-7460

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.42, 2013-12, pp. : 7451-7460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Nociceptin/Orphanin FQ Receptor (NOP) as a Target for Drug Abuse Medications

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 9, 2011-05 ,pp. : 1151-1156

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha1-Adrenergic Receptor Antagonists Use in Treatment and Prevention of Psychiatric Disorders: A Review

By Wadhawan Abhishek   Banga Alok   Duan Yinghui   Mennesson Michel   Helen Wu Zhao  

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 158-183

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha1-Adrenergic Receptor Antagonists Use in Treatment and Prevention of Psychiatric Disorders: A Review

By  

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 158-183

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 1-26

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 5, 2008-11 ,pp. : 442-453

Bentham Science Publishers

Access to resources Recommend Favorite